Rheumatoid arthritis is an autoimmune condition that can inflame joints and affect fatigue, grip, and day-to-day function. Rheumatoid arthritis medications usually fall into five broad groups: NSAIDs, corticosteroids, conventional DMARDs, biologic DMARDs, and JAK inhibitors. Some mainly ease pain and swelling. Others try to control the disease itself and limit joint damage over time. That distinction matters because short-term symptom relief and long-term disease control are not the same goal.
There is also no single best drug for everyone. Methotrexate is a common starting point, but the right plan depends on disease activity, other health conditions, pregnancy plans, infection risk, monitoring needs, and how a medicine fits daily life.
Key Takeaways
- Five broad drug classes are used in RA care.
- NSAIDs and steroids mainly relieve symptoms.
- DMARDs, biologics, and JAK inhibitors target disease activity.
- Methotrexate is often a common first long-term option.
- Safety, monitoring, route, and cost all shape the choice.
How Rheumatoid Arthritis Medications Fit Into Care
RA treatment usually tries to do two things at once: calm today’s inflammation and protect tomorrow’s joints. That is why a treatment plan may pair a faster-acting medicine with one that works more deeply over time. Rheumatology teams also tend to revisit the plan if symptoms stay active, rather than leaving an ineffective approach in place.
Symptom relief and disease control are not the same
Nonsteroidal anti-inflammatory drugs, or NSAIDs, can reduce pain and stiffness. Corticosteroids, also called glucocorticoids, can lower inflammation quickly. Both can be useful during a flare or while waiting for a slower medicine to start helping. But they do not usually serve as the main long-term strategy for controlling RA on their own.
Disease-modifying antirheumatic drugs, or DMARDs, are different. They target the inflammatory process more directly and may help slow disease activity and limit joint damage. Conventional DMARDs, biologics, and targeted synthetic drugs such as Janus kinase inhibitors all sit in this longer-term category. A person may use more than one class over time, and sometimes more than one class at once.
Why it matters: A medicine that eases pain today may not be the one that protects joints over time.
If you want broader context on autoimmune joint disease, the site’s Rheumatology hub is a browseable place to start.
BorderFreeHealth works with licensed Canadian partner pharmacies for eligible U.S. patients.
The 5 Main Medication Types Used for RA
The five major classes used in rheumatoid arthritis treatment are NSAIDs, corticosteroids, conventional synthetic DMARDs, biologic DMARDs, and JAK inhibitors. These are drug families, not interchangeable brand names. Each class fills a different role, and the same person may move from one class to another as goals, symptoms, or side effects change.
| Medication type | Main role | Examples | How it usually fits |
|---|---|---|---|
| NSAIDs | Reduce pain and stiffness | Ibuprofen, naproxen, celecoxib | Symptom relief; not a substitute for disease-modifying therapy |
| Corticosteroids | Rapid anti-inflammatory relief | Prednisone | Often short term or used as a bridge while slower drugs take effect |
| Conventional DMARDs | Target disease activity | Methotrexate, hydroxychloroquine, sulfasalazine, leflunomide | Often the first long-term treatment class |
| Biologic DMARDs | Block specific immune signals | TNF inhibitors and other biologics | Used when conventional DMARDs are not enough or not tolerated |
| JAK inhibitors | Oral targeted immune treatment | Tofacitinib, baricitinib | Another option when other DMARDs are insufficient or unsuitable |
NSAIDs: These drugs can reduce pain and swelling, but they do not change the underlying disease course. Common examples include Naproxen and Celecoxib. They may help daily function, yet stomach, kidney, blood pressure, and cardiovascular issues can matter, especially with longer use.
Corticosteroids: Steroids such as Prednisone can work quickly when inflammation is intense. Because side effects can build over time, clinicians often try to use them thoughtfully and reassess the plan instead of relying on them alone.
Conventional DMARDs: This class often forms the backbone of RA care. Methotrexate is the best-known example, while hydroxychloroquine, sulfasalazine, and leflunomide are also common. On the site, related product examples include Plaquenil and Arava. Some people use one DMARD. Others use a combination, especially if symptoms remain active.
Biologic DMARDs: Biologics are engineered medicines that target specific immune pathways. They are often considered when a conventional DMARD does not control symptoms well enough or is not tolerated. Examples on the site include Humira Prefilled Syringe and Enbrel SureClick. Many are injections, though some are given by infusion in a clinic.
JAK inhibitors: JAK inhibitors are targeted oral DMARDs. One example on the site is Xeljanz. They can help some people who need an option beyond older DMARDs, but they also come with important safety questions.
Is There a Best Drug for RA?
No single medicine is best for every person with RA. The better question is which option best fits the goals and risks of a specific person at a specific time. A medicine may look strong on paper but still be a poor fit if it causes side effects, requires monitoring that is hard to keep up with, or simply does not control the disease well enough.
Methotrexate is often a common starting DMARD because it has a long track record and can work well for many people. If disease activity is mild, another conventional DMARD may be reasonable. If inflammation stays active, a biologic or JAK inhibitor may be added or substituted. The plan may also change if side effects appear, lab tests shift, or life circumstances change.
It is also common for treatment to change step by step. Someone may start with a conventional DMARD, use a short steroid burst while waiting for it to work, and later move to a biologic or JAK inhibitor if the target is not met. If low disease activity or remission is reached, the discussion may shift toward maintaining control with the safest practical regimen.
What changes the first choice
- Disease activity level and joint damage risk
- How quickly symptom relief is needed
- Liver, kidney, lung, eye, or stomach concerns
- Past infections and vaccination status
- Pregnancy planning or breastfeeding questions
- Comfort with pills, self-injection, or infusions
Doctors also think about the practical side. A once-daily pill may feel easier than a shot, but storage, lab work, or side effects can still change the equation. For some people, avoiding frequent flares matters most. For others, a safer profile around another medical condition matters more.
When needed, prescription details are confirmed with the prescriber before a pharmacy dispenses medication.
Methotrexate and Hydroxychloroquine: Why the Choice Differs
Methotrexate and hydroxychloroquine are not direct substitutes in every case. Methotrexate is often used as an anchor drug because it can provide stronger disease control for many people with active RA. Hydroxychloroquine is sometimes chosen for milder disease, for combination therapy, or when a different safety or tolerability profile is preferred.
That does not make one universally better. Methotrexate often calls for closer lab monitoring and may be limited by liver issues, nausea, mouth sores, or pregnancy considerations. Hydroxychloroquine is often seen as gentler, but it may not be strong enough by itself for more active disease and it carries its own monitoring needs, including eye screening over time.
Sulfasalazine and leflunomide sit in this same conventional DMARD conversation. They may be used alone or combined when methotrexate is not enough or not a good fit. In other words, the real comparison is usually less about picking a winner and more about matching the medicine to disease severity, safety concerns, and what a person can realistically stay on.
Quick tip: Keep an updated list of medicines, supplements, and recent lab dates before any treatment review.
Side Effects and Monitoring for Rheumatoid Arthritis Medications
Side effects vary by class, and that is one reason regular medication reviews matter. The goal is not only symptom control. It is finding a treatment balance that remains safe and workable over time.
NSAIDs can irritate the stomach and may affect kidneys, blood pressure, or cardiovascular risk. Corticosteroids can raise blood sugar, affect mood and sleep, and increase longer-term concerns such as bone loss or weight gain. Those trade-offs help explain why quick relief does not always mean best long-term fit.
Conventional DMARDs often need blood tests to watch liver function, blood counts, or other markers. Methotrexate may cause nausea, mouth sores, or lab changes. Hydroxychloroquine has different concerns and is known for eye monitoring over long-term use. Biologics and JAK inhibitors can raise infection concerns, so screening for issues such as tuberculosis or hepatitis, along with vaccine review, may be part of treatment planning.
Some targeted therapies, especially JAK inhibitors, also carry important boxed warnings. That does not mean they are wrong for everyone. It means the risk discussion should be specific, informed, and revisited as health conditions change.
Reasons people switch rheumatoid arthritis medications often include:
- Active symptoms despite treatment
- Side effects or abnormal lab results
- Frequent infections or new health issues
- Pregnancy planning or changing life circumstances
- Problems with route, schedule, or cost
Seek urgent medical care for severe allergic reactions, chest pain, trouble breathing, sudden one-sided leg swelling, or signs of a serious infection. For new or worsening side effects that feel less urgent, a prompt review with the prescribing clinician is the safer next step.
Starting or Switching Treatment: Practical Questions That Matter
Starting or switching treatment usually means balancing disease control with practical fit. Pills, self-injections, clinic infusions, lab schedules, storage needs, and out-of-pocket cost can all affect whether a plan is realistic.
When people compare rheumatoid arthritis medications, convenience is only one piece. A weekly medicine may sound easier than a daily one, but monitoring or side effects may tip the balance. An injection may feel intimidating at first, yet some people prefer less frequent dosing once they learn the routine. Others want to avoid refrigeration, needles, or infusion visits.
Route matters too. Oral medications for rheumatoid arthritis include several conventional DMARDs and JAK inhibitors. Rheumatoid arthritis injections often include many biologics, though some steroid treatments and other drugs may also be injected. Infusions add another layer because they usually happen in a clinic rather than at home.
Cost and access can shape the plan just as much as pharmacology. Some medicines have generic or biosimilar options. A biosimilar is a highly similar version of an existing biologic. One example on the site is Erelzi. Other treatments may involve specialty handling, prior authorization, refrigeration, or injection training. None of those issues decide what is medically appropriate, but they often influence what is workable in real life.
- What is the main goal of this medication?
- How will response be checked over time?
- What lab tests or screenings are expected?
- What side effects should trigger a call?
- Is a pill, injection, or infusion more realistic?
- Are storage, travel, or work schedules important?
- How might coverage or cash-pay costs affect access?
Cash-pay cross-border options may be available for some patients without insurance, depending on eligibility and jurisdiction.
Putting the 5 Types in Perspective
Rheumatoid arthritis medications are best understood as a toolkit, not a single winner. NSAIDs and steroids can help with pain and swelling. DMARDs, biologics, and JAK inhibitors are the classes more directly aimed at disease control. The best plan is often the one that balances control, safety, and the reality of staying on treatment.
Most rheumatoid arthritis medications fit into a broader plan rather than working alone. If you are sorting through names that sound similar, start with three questions: Is this mainly for symptom relief or disease control? How is it taken and monitored? What trade-offs matter most in everyday life? That simple frame makes comparisons much clearer.
Authoritative Sources
- For broad treatment basics, review the Mayo Clinic overview of rheumatoid arthritis diagnosis and treatment.
- For patient-friendly background, see the Arthritis Foundation summary of rheumatoid arthritis treatments.
- For safety context on JAK inhibitors, read the FDA safety communication on major JAK inhibitor warnings.
This content is for informational purposes only and is not a substitute for professional medical advice.
